임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 중단 (진행 중)· Type 2 Diabetes MellitusA Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes
리드: 로슈
- 2상모집 중단 (진행 중)· Obesity or OverweightA Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity
리드: 로슈
- 2상모집 중단 (진행 중)· Duchenne Muscular DystrophyA Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)
리드: 로슈
- 2상모집 중단 (진행 중)· Atopic DermatitisA Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
리드: 로슈
- 2상모집 중단 (진행 중)· Microsatellite Stable (MSS) Colorectal Cancer (CRC)Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer
협력: 로슈
- 2상모집 중단 (진행 중)· Mantle Cell LymphomaGATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma
협력: 애브비, 일라이 릴리, 로슈
- 2상모집 중단 (진행 중)· Overweight or ObeseA Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
협력: 로슈
- 2상모집 중단 (진행 중)· HER2-positive Breast CancerPHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer
협력: 로슈
- 2상모집 중단 (진행 중)· Hepatocellular CarcinomaA Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
리드: 로슈
- 2상모집 중단 (진행 중)· Alzheimer's DiseaseA Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)
리드: 로슈
- 2상모집 중단 (진행 중)· Triple Negative Breast CancerTiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer
협력: 로슈
- 2상모집 중단 (진행 중)· Colorectal CancerClinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer
협력: 로슈
- 2상모집 중단 (진행 중)· Duchenne Muscular DystrophyA Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)
리드: 로슈
- 2상모집 중단 (진행 중)· Follicular LymphomaTazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma
협력: 로슈
- 2상모집 중단 (진행 중)· Crohns DiseaseAfimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease
리드: 로슈
- 2상모집 중단 (진행 중)· Follicular LymphomaGlofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma
협력: 로슈
- 2상모집 중단 (진행 중)· Relapsed/Refractory Multiple MyelomaCevostamab Following CAR T Cell Therapy for RRMM
협력: 로슈
- 2상모집 중단 (진행 중)· Endometrial CancerA Study of Giredestrant in Participants With Grade 1 Endometrial Cancer
리드: 로슈
- 2상모집 중단 (진행 중)· Leukemia, Lymphocytic, Chronic, B-CellZanubrutinib and Venetoclax as Initial Therapy for Chronic Lymphocytic Leukemia (CLL) With Response-based Obinutuzumab
협력: 로슈
- 2상모집 중단 (진행 중)· Lymphoma, Large B-Cell, DiffuseRituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP
협력: 로슈
- 2상모집 중단 (진행 중)· Non-small Cell Lung CancerA Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer
리드: 로슈
- 2상모집 중단 (진행 중)· Facioscapulohumeral Muscular Dystrophy (FSHD)A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy
리드: 로슈
- 2상모집 중단 (진행 중)· Metastatic Breast CancerFulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression
협력: 화이자, 로슈
- 2상모집 중단 (진행 중)· Lung Non-Small Cell CarcinomaSubcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer
협력: 로슈
- 2상모집 중단 (진행 중)· Lymphoma, FollicularMosunetuzumab and Polatuzumab Vedotin for Untreated Follicular Lymphoma
협력: 로슈
- 2상모집 중단 (진행 중)· Colorectal Cancer MetastaticSafety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.
협력: 로슈
- 2상모집 중단 (진행 중)· Relapsing Multiple SclerosisA Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)
리드: 로슈
- 2상모집 중단 (진행 중)· Non-Hodgkin LymphomaA Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies
리드: 로슈
- 2상모집 중단 (진행 중)· Non-squamous Non-small-cell Lung CancerTiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC
협력: 로슈
- 2상모집 중단 (진행 중)· DLBCLA Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL
협력: 로슈
- 2상모집 중단 (진행 중)· Early Breast CancerChemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer
협력: 로슈
- 2상모집 중단 (진행 중)· Hepatocellular CarcinomaAn Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)
협력: 로슈
- 2상모집 중단 (진행 중)· Chronic Lymphocytic LeukemiaA Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL
협력: 아스트라제네카, 로슈
- 2상모집 중단 (진행 중)· Parkinsons DiseaseA Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease
리드: 로슈
- 2상모집 중단 (진행 중)· Colorectal Cancer Stage IIA Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
리드: 바이오엔테크 · 협력: 로슈
- 2상모집 중단 (진행 중)· Ann Arbor Stage II Follicular LymphomaObinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma
협력: 로슈
- 2상모집 중단 (진행 중)· Solid TumorsTumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
리드: 로슈
- 2상모집 중단 (진행 중)· Chronic Myelomonocytic Leukemia (CMML)Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations
협력: 로슈
- 2상모집 중단 (진행 중)· HER2-positive Breast CancerA Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
협력: 로슈
- 2상모집 중단 (진행 중)· Chronic Lymphocytic Leukemia (CLL)The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL)
협력: 로슈
- 2상모집 중단 (진행 중)· Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerA Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
리드: 로슈
- 2상모집 중단 (진행 중)· Immune-related Adverse EventsStudy of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)
협력: 로슈
- 2상모집 중단 (진행 중)· Clinical Stage III Cutaneous Melanoma AJCC v8A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma
협력: 로슈
- 2상모집 중단 (진행 중)· Lung CancerAdjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)
협력: 로슈
- 2상모집 중단 (진행 중)· Bladder CancerStudy of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer
협력: 로슈
- 2상모집 중단 (진행 중)· Metastatic Prostate CancerStudy of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
협력: 로슈
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.